XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (14268)	8/1/2000 12:14:23 AM
From: aknahow	Read Replies (1) of 17367

Cacaito, my point was not that XOMA was going to release good news but rather that your post are becoming less valuable because you seem to be getting carless in your desire to show that XOMA is worthless. There is no logical reason good news, that has not yet happened, which is of the mature of signing an agreement can't be delayed to some extent. I have for some time, in the clubhouse, asked why a Chiron patent says gelonin does not work in vivo. I asked for a serious response by anyone that knows. You may think Neuprex does not work. Suppose you are right. Do you agree that the peptides of BPI including the xmp Mycoprex peptides are up to 10,000 times more potent than BPI?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next